loading...| Preferred Name |
volinanserin |
| Synonyms |
M100907 |
| ID |
http://purl.bioontology.org/ontology/MESH/C079049 |
| altLabel |
M100907 MDL-100,907 MDL100105 MDL 100907 alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol MDL-100907 MDL 100,907 MDL 100105 (R)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol 4-piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-R)- |
| cui |
C0212181 C0212182 C0656634 |
| HM |
D005464 D010880 |
| Inverse of RB |
EW71EE171J |
| isa | |
| Mapped to | |
| MDA |
19930203 |
| MeSH Frequency |
301 |
| MMR |
20161019 |
| notation |
C079049 |
| PA |
D012702 |
| prefLabel |
volinanserin |
| RR |
139290-65-6 |
| SC |
1 |
| Scope Statement |
blocks 3,4-methylenedioxymethamphetamine (MDMA)-stimulated dopamine synthesis in vivo without affecting basal synthesis |
| SRC |
Eur J Pharmacol 1992 Nov 13;223(1):65-74 |
| TERMUI |
T426204 T241731 T000910051 T241732 T241729 T000910052 T241728 T241730 T000910053 T241727 T426203 |
| TH |
NLM (2017) NLM (1993) FDA SRS (2017) NLM (2000) INN (19XX) |
| tui |
T109 T121 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C95220 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |